The Precision Peptide Company Inc. (CSE:BPC)
Canada flag Canada · Delayed Price · Currency is CAD
0.3500
+0.0050 (1.45%)
Oct 9, 2026, 3:50 PM EST

CSE:BPC Revenue

The Precision Peptide Company had revenue of 64.14K CAD in the quarter ending July 31, 2026, with 984.20% growth. This brings the company's revenue in the last twelve months to 167.35K, up 2,292.02% year-over-year. In the fiscal year ending October 31, 2025, The Precision Peptide Company had annual revenue of 49.72K with 307.47% growth. That makes The Precision Peptide Company the 45,877th largest company in the world by revenue and 1,046th in Canada.

Revenue (ttm)
167.35K
Revenue Growth
+2,292.02%
P/S Ratio
116.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
19.47M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Oct 31, 202549.72K37.52K307.47%
Oct 31, 202412.20K-273.39K-95.73%
Oct 31, 2023285.59K-295.40K-50.84%
Oct 31, 2022580.99K463.57K394.79%
Oct 31, 2021117.42K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.